Tofacitinib citrate clinical trials

A3921145 - A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)

This study is looking at the long-term safety and effects of a medicine called tofacitinib for treating juvenile idiopathic arthritis (JIA) in young people. Researchers will check things like growth, overall health, and how well the medicine controls their JIA.